1. Home
  2. SEAT vs PCRX Comparison

SEAT vs PCRX Comparison

Compare SEAT & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivid Seats Inc.

SEAT

Vivid Seats Inc.

HOLD

Current Price

$6.60

Market Cap

82.9M

Sector

Industrials

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.96

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEAT
PCRX
Founded
2001
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.9M
1.0B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
SEAT
PCRX
Price
$6.60
$25.96
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
$32.94
$32.86
AVG Volume (30 Days)
139.7K
870.0K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.47
Revenue
$643,775,000.00
$716,791,000.00
Revenue This Year
N/A
$6.24
Revenue Next Year
N/A
$9.53
P/E Ratio
N/A
$55.21
Revenue Growth
N/A
3.14
52 Week Low
$6.15
$18.17
52 Week High
$100.00
$27.64

Technical Indicators

Market Signals
Indicator
SEAT
PCRX
Relative Strength Index (RSI) 36.30 60.19
Support Level $6.15 $25.48
Resistance Level $6.77 $27.16
Average True Range (ATR) 0.54 1.02
MACD 0.08 0.01
Stochastic Oscillator 20.47 67.69

Price Performance

Historical Comparison
SEAT
PCRX

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: